Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its ...

Just a few years ago, children with Type 1 diabetes reported to the school nurse several times a day to get a finger pricked ...

Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market - Targeting Q1 2026 for expected clearance of the MODD1 in ...

Dr Hamish Crocket, Senior Lecturer at the University of Waikato’s School of Health Equity and Innovation, will co-lead the $1 ...

MAHTAB SOHREVARDI ENDOCRINOLOGY Physician Huntington Health Dr. Mahtab Sohrevardi’s area of interest is thyroidal disorders ...

The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.

Transforming global health demands smart chemistry, addressing urgent health challenges through innovative, durable medical ...

What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Walter, SVP at Medtronic, exercising stock options for 1,337 shares of MDT. The total ...

Corporation's stock has reached a new 52-week high, with shares climbing to $282.87. This milestone reflects a significant uptrend for the medical device company, known for its innovative insulin pump ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...